Skip to content
  • Home
  • Book Bag: 0 items (Full)
    • English
    • 日本語
    • 中文(简体)
    • 中文(繁體)
    • اللغة العربية
  • About
Advanced
  • Editorial: HIV/HBV and/or HCV...
  • Cite this
  • Text this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Add to Book Bag Remove from Book Bag
  • Permanent link

Editorial: HIV/HBV and/or HCV infections and hepatotoxicity in pregnant and non-pregnant women

Bibliographic Details
Published in:Frontiers in Reproductive Health
Main Authors: George Uchenna Eleje, Chinyere Ukamaka Onubogu, Emeka Philip Igbodike, Sayeed Mohammed Firdous
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-08-01
Subjects:
co-infections
vaccination coverage
antiviral treatments
mother-to-child transmission (MTCT)
HBsAg-positive
Online Access:https://www.frontiersin.org/articles/10.3389/frph.2025.1538380/full
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

https://www.frontiersin.org/articles/10.3389/frph.2025.1538380/full

Similar Items

  • Decreasing hepatitis B seroprevalence in pregnant women in Taiwan between 2016 and 2021: a claim-based cohort study
    by: Li-Nien Chien, et al.
    Published: (2025-01-01)
  • HBeAg testing is better than quantitative HBsAg assay as an alternative to HBV DNA assay among HBV-infected pregnant women
    by: Minh Ngoc Nguyen, et al.
    Published: (2023-10-01)
  • Unexpected rise in the circulation of complex HBV variants enriched of HBsAg vaccine-escape mutations in HBV genotype-D: potential impact on HBsAg detection/quantification and vaccination strategies
    by: Lorenzo Piermatteo, et al.
    Published: (2023-12-01)
  • Key mutations in the C-terminus of the HBV surface glycoprotein correlate with lower HBsAg levels in vivo, hinder HBsAg secretion in vitro and reduce HBsAg structural stability in the setting of HBeAg-negative chronic HBV genotype-D infection
    by: Romina Salpini, et al.
    Published: (2020-01-01)
  • Lower pretreatment HBV DNA levels are associated with better off-treatment outcomes after nucleo(s)tide analogue withdrawal in patients with HBeAg-neegative chronic hepatitis B: A multicentre cohort study
    by: Milan J. Sonneveld, et al.
    Published: (2023-08-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs